Product Information

TAMOXIFEN 10 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1332 per EA under NDC 00378014491. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 20, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TAMOXIFEN 10 MG TABLET

Tamoxifen Citrate
$0.1332per EA

Strength

10 mg/1

NDC

00378014491

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TAMOXIFEN CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA074732

FDA Approved

2/20/2003

TE Code

AB

On Market Since

2/20/2003

Pharmacological Classes

Estrogen Agonist/Antagonist
Selective Estrogen Receptor Modulators

Price Statistics

The NADAC for TAMOXIFEN 10 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 31.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1332 per EA
All-time high$0.3311 (Jun 13, 2018)
All-time low$0.0950 (Jul 17, 2024)
52-week high$0.1815
52-week low$0.1257
Median price$0.2344
Average price$0.2245
Largest weekly change+59.5% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.3%

1M

+2.3%

3M

+6.0%

6M

-9.3%

1Y

-26.6%

3Y

-23.0%

5Y

-19.7%

All

-31.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TAMOXIFEN 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TAMOXIFEN 10 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1332 per EA (NDC 00378014491), effective Aug 19, 2026.

How has the price of TAMOXIFEN 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for TAMOXIFEN 10 MG TABLET has declined 31.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TAMOXIFEN 10 MG TABLET?

Since Nov 28, 2013, the NADAC for TAMOXIFEN 10 MG TABLET has ranged from a low of $0.0950 (Jul 17, 2024) to a high of $0.3311 (Jun 13, 2018), with a median of $0.2344 per EA.

Are there cheaper alternatives to TAMOXIFEN 10 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TAMOXIFEN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TAMOXIFEN 10 MG TABLET?

TAMOXIFEN 10 MG TABLET (NDC 00378014491) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.